Sunday, August 20, 2006 8:18:14 PM
Monday August 14, 7:00 pm ET
EDEN PRAIRIE, Minn., Aug. 14 /PRNewswire-FirstCall/ -- NVE Corporation (Nasdaq: NVEC - News) announced that James D. Hartman, Chairman of the Board of Enpath Medical, Inc. (Nasdaq: NPTH - News), was elected to NVE's board of directors at the NVE annual meeting of shareholders held today.
Hartman, 60, replaces NVE Founder James M. Daughton, Ph.D. on NVE's board of directors. Daughton, 69, retired as an NVE director and officer effective with the annual meeting today but remains a company employee.
Each of NVE's other incumbent directors was reelected to serve on the board of directors until the company's 2007 annual meeting. Hartman is expected to be elected to the company's audit committee by the board of directors.
Hartman joined Enpath in 1991 and was Enpath's chief executive officer from February 1996 until retiring from that position in January 2006. Enpath is a medical products company engaged in designing, developing, manufacturing, and marketing products and accessories for the cardiac rhythm management, neuromodulation and interventional radiology markets as well as manufacturing of medical devices and components for other medical product companies on a contract basis. Prior to joining Enpath, Mr. Hartman was Vice President- Finance for Viking Electric Supply, Inc., a distributor of electrical supplies and tools.
"We are delighted to have Jim Hartman join our board," said NVE President and Chief Executive Officer Daniel A. Baker, Ph.D. "He has a wealth of business experience, particularly in the medical device industry. Furthermore, his experience running a public company and his financial expertise will help NVE continue to meet the highest standards for corporate governance."
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that many experts believe represents the next generation of microelectronics. NVE licenses its MRAM intellectual property and sells spintronic sensors and couplers to revolutionize data sensing and transmission.
Statements used in this press release that relate to future plans, events, financial results or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as risks related to attracting and retain highly-qualified employees, risks related to legal proceedings, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K and other reports filed with the SEC.
Source: NVE Corporation
Recent NVEC News
- NVE Schedules Conference Call on Fourth-Quarter and Fiscal Year Results • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:05:16 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 04:26:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:24:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:20:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/24/2024 03:17:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/17/2024 09:11:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:08:54 PM
- NVE Schedules Conference Call on Third-Quarter Results • GlobeNewswire Inc. • 01/10/2024 09:05:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/03/2024 09:05:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/18/2023 08:10:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:05:37 PM
- NVE Schedules Conference Call on Second-Quarter Results • GlobeNewswire Inc. • 10/11/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 09:17:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 09:05:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 08:57:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 08:50:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:45:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/19/2023 08:10:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:02:49 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/19/2023 08:02:18 PM
- NVE Schedules Conference Call on First-Quarter Results • GlobeNewswire Inc. • 07/12/2023 08:05:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM